In the recommended dosages, the blue shade of the finished product is very diluted and does not produce residual coloring on the hair strands or scalp
CagriSema is investigational under FDA review with a decision expected in 2026, not yet approved [4]
DNA methylation at CpG sites across the genome changes in systematic, age-predictive patterns that are measurable as "epigenetic age" with biological epigenetic age sometimes running ahead of or behind chronological age based on genetics, lifestyle, and metabolic health
Take the first step toward a healthier you by exploring this effective treatment option
17: 737-42 Diegeler A, Doll N, Rauch T, et al
Dihexa & Alzheimer's Disease Research Alzheimer's disease was the original target for Dihexa development